Jefferies Financial Group Inc. Invests $2.79 Million in Alignment Healthcare, Inc. $ALHC

Jefferies Financial Group Inc. bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) during the 2nd quarter, Holdings Channel reports. The firm bought 117,396 shares of the company’s stock, valued at approximately $2,795,000.

Several other hedge funds have also added to or reduced their stakes in the company. Bank of America Corp DE boosted its position in shares of Alignment Healthcare by 156.5% in the 1st quarter. Bank of America Corp DE now owns 3,215,667 shares of the company’s stock valued at $56,660,000 after purchasing an additional 1,961,778 shares during the period. 1492 Capital Management LLC raised its holdings in Alignment Healthcare by 61.8% during the 4th quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock worth $6,416,000 after buying an additional 124,143 shares during the period. Danica Pension Livsforsikringsaktieselskab purchased a new stake in Alignment Healthcare during the fourth quarter valued at about $39,500,000. William Blair Investment Management LLC lifted its stake in Alignment Healthcare by 8.7% during the fourth quarter. William Blair Investment Management LLC now owns 2,305,255 shares of the company’s stock valued at $45,529,000 after buying an additional 185,303 shares in the last quarter. Finally, Simplify Asset Management Inc. boosted its holdings in shares of Alignment Healthcare by 92.0% in the fourth quarter. Simplify Asset Management Inc. now owns 262,880 shares of the company’s stock worth $5,192,000 after buying an additional 125,946 shares during the period. 86.19% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

ALHC has been the topic of several analyst reports. Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. KeyCorp restated an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Zacks Research lowered shares of Alignment Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Barclays decreased their target price on Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating for the company in a research report on Tuesday, May 26th. Finally, JPMorgan Chase & Co. lowered their price target on Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, August 4th. Seven analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $23.60.

Alignment Healthcare Stock Up 0.4%

Alignment Healthcare stock opened at $13.62 on Friday. Alignment Healthcare, Inc. has a twelve month low of $12.70 and a twelve month high of $25.12. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.70 and a current ratio of 1.70. The firm has a market cap of $2.83 billion, a PE ratio of 71.69 and a beta of 1.10. The firm’s 50 day moving average price is $18.09 and its two-hundred day moving average price is $18.53.

Alignment Healthcare (NASDAQ:ALHC) last posted its quarterly earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, beating the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The business had revenue of $1.34 billion for the quarter, compared to analysts’ expectations of $1.31 billion. During the same period in the previous year, the company posted $0.07 EPS. Alignment Healthcare’s revenue was up 31.6% on a year-over-year basis. On average, research analysts predict that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Hyong Kim sold 35,951 shares of Alignment Healthcare stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $19.86, for a total transaction of $713,986.86. Following the completion of the sale, the insider directly owned 331,750 shares in the company, valued at $6,588,555. The trade was a 9.78% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John E. Kao sold 298,000 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $13.88, for a total value of $4,136,240.00. Following the completion of the sale, the chief executive officer directly owned 790,766 shares of the company’s stock, valued at approximately $10,975,832.08. The trade was a 27.37% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 1,009,951 shares of company stock worth $18,597,287. Insiders own 5.20% of the company’s stock.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.